BioVie regains Nasdaq minimum bid price compliance after 10-day $1 closing streak

BIOVIE INC.

Received Nasdaq compliance letter on August 20, 2024 for Bid Price Rule (5550(a)(2)).
Bid price closed at or above $1.00 for 10 consecutive business days (Aug 6–19, 2024).
Previously disclosed bid price deficiency in April 2024; now resolved.
Company states it will continue to work to adhere to Nasdaq listing standards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.